Mayor Michael Bloomberg announced that Memorial Sloan-Kettering plans to build a new outpatient cancer care facility on the Upper East Side of Manhattan.
Medical oncologist Heather McArthur, radiologist David Dershaw, and surgical oncologist Monica Morrow discussed the latest advances in the diagnosis and treatment for breast cancer. Clinical nurse specialist Donna Wilson also spoke about her dragon boat team made up entirely of breast cancer survivors.
Hematologist/oncologist Katharine Hsu spoke about a study she led that found that genetic features of stem cell transplant donors may be associated with a reduced risk of relapse in acute myelogenous leukemia patients.
Medical oncologist Howard Scher commented on the US Food and Drug Administration’s approval of enzalutamide for the treatment of men with metastatic prostate cancer. Laboratory work conducted by researcher and Human Oncology and Pathogenesis Program Chair Charles Sawyers was instrumental in the development of this novel therapy.
Good Morning America co-host Robin Roberts said goodbye to her colleagues before going on medical leave to receive a bone marrow transplant at Memorial Sloan-Kettering. Hematologist-oncologist and Chief of the Adult Bone Marrow Transplant Service Sergio Giralt is one of Robin’s doctors.
Medical oncologist Clifford Hudis commented on a study that found that being moderately overweight is linked to a higher risk of breast cancer recurrence.
Surgeon William Jarnagin described how he used an organ positioning system to remove a cancerous liver tumor in Memorial Sloan-Kettering patient Richie Rubin.
Cancer researcher and Human Oncology and Pathogenesis Program member David Solit spoke about a study he led that sequenced the entire genome of a patient whose cancer disappeared when she took an experimental drug that didn’t help others.
Directors of Memorial Sloan-Kettering’s long-term follow-up programsKevin Oeffinger and Charles Sklar authored a commentary on a study that found that cancer patients who underwent radiation therapy as children are at greater risk of developing diabetes later in life.
Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton commented on Memorial Sloan-Kettering’s collaboration with IBM to develop a decision-support tool based upon the IBM Watson system.
Prostate cancer surgeon James Eastham spoke about screening men for prostate cancer. BRCA gene mutations, which are ten times more common in Ashkenazi Jews, can increase the risk for breast, ovarian, and prostate cancers.
Medical oncologist Leonard Saltz commented on a late-stage clinical trial of an experimental drug for pancreatic cancer that was halted after an outside monitoring panel concluded that the drug was unlikely to improve the survival of patients with an advanced form of the disease.
Radiologist Carol Lee commented on a new law that requires doctors to inform women with dense breast tissue that this makes detecting breast cancer more difficult and may be associated with an increased risk of cancer.
Medical oncologist and geneticist Zsofia Stadler discussed a study she led that found that some early-onset testicular cancers may result from spontaneous, or de novo, genetic changes. These de novo mutations are not inherited from either parent, but arise in either the egg or sperm cell or sometime during embryonic development.
